pargyline has been researched along with Liver Dysfunction in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, T | 1 |
| Suzuki, O | 1 |
| Furuta, T | 1 |
| Asai, M | 1 |
| Kurokawa, Y | 1 |
| Nimura, Y | 1 |
| Katsumata, Y | 1 |
| Takahashi, I | 1 |
1 other study available for pargyline and Liver Dysfunction
| Article | Year |
|---|---|
A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate.
Topics: Heart Failure; Humans; Hydrogen-Ion Concentration; Kinetics; Kynuramine; Liver Diseases; Monoamine O | 1985 |